School of Health Sciences, Kristiana University College, PB 1190, Sentrum, 0107, Oslo, Norway.
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Trials. 2023 Mar 11;24(1):179. doi: 10.1186/s13063-023-07211-5.
Around one-third of workdays lost in Norway are due to musculoskeletal conditions, with persistent (chronic) pain being the most frequent cause of sick leave and work disability. Increasing work participation for people with persistent pain improves their health, quality of life, and well-being and reduces poverty; however, it is not clear how to best help unemployed people who have persistent pain to return to work. The aim of this study is to examine if a matched work placement intervention featuring case manager support and work-focused healthcare improves return to work rates and quality of life for unemployed people in Norway with persistent pain who want to work.
We will use a cohort randomised controlled approach to test the effectiveness and cost-effectiveness of a matched work placement intervention featuring case manager support and work-focused healthcare compared to those receiving usual care in the cohort alone. We will recruit people aged 18-64, who have been out of work for at least 1 month, had pain for more than 3 months, and want to work. Initially, all (n = 228) will be recruited to an observational cohort study on the impact of being unemployed with persistent pain. We will then randomly select one in three to be offered the intervention. The primary outcome of sustained return to work will be measured using registry and self-reported data, while secondary outcomes include self-reported levels of health-related quality of life and physical and mental health. Outcomes will be measured at baseline and 3, 6, and 12 months post-randomisation. We will run a process evaluation parallel to the intervention exploring implementation, continuity of the intervention, reasons for participating, declining participation, and mechanisms behind cases of sustained return to work. An economic evaluation of the trial process will also be conducted.
The ReISE intervention is designed to increase work participation for people with persistent pain. The intervention has the potential to improve work ability by collaboratively navigating obstacles to working. If successful, the intervention may be a viable option for helping people in this population.
ISRCTN Registry 85,437,524 Registered on 30 March 2022.
在挪威,约有三分之一的工作日损失是由于肌肉骨骼疾病造成的,持续性(慢性)疼痛是请病假和工作残疾的最常见原因。增加持续性疼痛患者的工作参与度可以改善他们的健康、生活质量和幸福感,并减少贫困;然而,目前尚不清楚如何最好地帮助持续性疼痛且失业的人重返工作岗位。本研究旨在检验以个案经理支持和以工作为重点的医疗保健为特色的匹配工作安置干预措施是否能提高希望工作的挪威持续性疼痛失业者的重返工作率和生活质量。
我们将采用队列随机对照方法,检验以个案经理支持和以工作为重点的医疗保健为特色的匹配工作安置干预措施与仅在队列中接受常规护理的人相比,对至少失业 1 个月、疼痛持续 3 个月以上且希望工作的 18-64 岁人群的有效性和成本效益。最初,所有(n=228)人都将被招募到一项关于持续性疼痛失业影响的观察性队列研究中。然后,我们将随机选择三分之一的人提供干预措施。持续重返工作的主要结果将使用登记和自我报告数据进行测量,而次要结果包括自我报告的健康相关生活质量水平以及身体和心理健康状况。结果将在基线和随机分组后 3、6 和 12 个月进行测量。我们将并行进行一项过程评估,以探索实施情况、干预的连续性、参与的原因、拒绝参与的原因以及持续重返工作的案例背后的机制。还将对试验过程进行经济评估。
ReISE 干预措施旨在提高持续性疼痛患者的工作参与度。该干预措施有可能通过协作解决工作障碍来提高工作能力。如果成功,该干预措施可能是帮助该人群的可行选择。
ISRCTN Registry 85437524,于 2022 年 3 月 30 日注册。